• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿膀胱输尿管反流内镜抗反流手术后的长期疗效:尿路感染、肾瘢痕形成和手术成功的预测因素。

Long-term Outcomes of Endoscopic Anti-reflux Surgery in Pediatric Patients with Vesicoureteral Reflux: Urinary Tract Infection, Renal Scarring, and Predictive Factors for Success.

机构信息

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Korean Med Sci. 2018 Aug 8;33(38):e240. doi: 10.3346/jkms.2018.33.e240. eCollection 2018 Sep 17.

DOI:10.3346/jkms.2018.33.e240
PMID:30224908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6137031/
Abstract

BACKGROUND

To report the long-term outcomes of endoscopic surgery (ES) in pediatric patients with vesicoureteral reflux in terms of success rate, urinary tract infection, and renal function.

METHODS

We retrospectively reviewed the records of 73 pediatric patients (110 ureters) who underwent ES for vesicoureteral reflux. Ultrasonography was performed 1, 3, and 12 months postoperatively. Voiding cystourethrography was performed 3 months postoperatively and repeated after 1 year if vesicoureteral reflux persisted. Success was defined as the absence of reflux at the first voiding cystourethrography. Renal scans were performed at least 12 months postoperatively. Renal function deterioration was defined as a new scar or a greater than 5% decrease in function.

RESULTS

The median follow-up duration was 24 (12-118) months. The overall success was 65.6%, while it was 78.9%, 87.0%, 62.5%, 37.5%, 66.7% for grades I, II, III, IV, and V, respectively. In multivariate analyses, significant predictive factors for success were vesicoureteral reflux grade (odds ratio [OR], 0.28; < 0.001) and mound detection at the first postoperative ultrasonography (OR, 13.53; < 0.001). Renal function deterioration was found in 8 (15.3%) ureters and was less common in those with successful surgeries than in those with failures (9.5% vs. 40.0%; = 0.035). No significant predictive factor for renal function deterioration or urinary tract infection was found.

CONCLUSION

Successful short-term outcomes of ES are expected in low-grade vesicoureteral reflux, especially when a mound is detected by postoperative ultrasonography. However, unpredictable long-term renal deterioration warrants continued follow-up.

摘要

背景

本研究旨在报告儿童膀胱输尿管反流患者内镜手术(ES)的长期疗效,包括成功率、尿路感染和肾功能。

方法

我们回顾性分析了 73 例(110 侧输尿管)接受 ES 治疗的小儿膀胱输尿管反流患者的临床资料。术后 1、3 和 12 个月行超声检查。术后 3 个月行排尿性膀胱尿道造影(VCUG),如果存在反流则于 1 年后重复检查。首次 VCUG 无反流定义为手术成功。术后至少 12 个月行肾扫描。如果出现新发瘢痕或功能下降超过 5%则定义为肾功能恶化。

结果

中位随访时间为 24(12-118)个月。总体手术成功率为 65.6%,Ⅰ、Ⅱ、Ⅲ、Ⅳ和Ⅴ级的成功率分别为 78.9%、87.0%、62.5%、37.5%和 66.7%。多因素分析显示,影响手术成功率的因素包括膀胱输尿管反流级别(比值比 [OR],0.28; < 0.001)和术后首次超声检查发现丘状结构(OR,13.53; < 0.001)。8 侧输尿管(15.3%)出现肾功能恶化,手术成功组肾功能恶化发生率低于手术失败组(9.5%比 40.0%; = 0.035)。未发现肾功能恶化或尿路感染的预测因素。

结论

对于低级别膀胱输尿管反流,ES 短期疗效较好,特别是术后超声检查发现丘状结构时。然而,长期肾功能不可预测的恶化仍需要密切随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119b/6137031/a6010e57b097/jkms-33-e240-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119b/6137031/2c5ca41be21d/jkms-33-e240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119b/6137031/a6010e57b097/jkms-33-e240-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119b/6137031/2c5ca41be21d/jkms-33-e240-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/119b/6137031/a6010e57b097/jkms-33-e240-g002.jpg

相似文献

1
Long-term Outcomes of Endoscopic Anti-reflux Surgery in Pediatric Patients with Vesicoureteral Reflux: Urinary Tract Infection, Renal Scarring, and Predictive Factors for Success.小儿膀胱输尿管反流内镜抗反流手术后的长期疗效:尿路感染、肾瘢痕形成和手术成功的预测因素。
J Korean Med Sci. 2018 Aug 8;33(38):e240. doi: 10.3346/jkms.2018.33.e240. eCollection 2018 Sep 17.
2
Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.内镜下注射葡聚糖/透明质酸作为 851 例高级别膀胱输尿管反流患儿的一线治疗:疗效和长期结果。
J Urol. 2018 Sep;200(3):650-655. doi: 10.1016/j.juro.2018.03.074. Epub 2018 Mar 15.
3
Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?影响膀胱输尿管反流内镜治疗成功的因素及两种基于葡聚糖omer的填充剂的比较:填充物质重要吗?
J Pediatr Urol. 2015 Apr;11(2):90.e1-5. doi: 10.1016/j.jpurol.2014.12.009. Epub 2015 Mar 2.
4
Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.膀胱输尿管反流内镜成功矫正后的肾瘢痕形成和尿路感染
J Urol. 2009 Oct;182(4 Suppl):1703-6. doi: 10.1016/j.juro.2009.03.011. Epub 2009 Aug 18.
5
Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux.1551 例中重度膀胱输尿管反流患儿行内镜下透明质酸钠/聚糖酐微球注射一线治疗的单中心经验
J Urol. 2012 Oct;188(4 Suppl):1485-9. doi: 10.1016/j.juro.2012.02.023. Epub 2012 Aug 17.
6
Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup.右旋糖酐/透明质酸注射治疗膀胱输尿管反流的长期随访:晚期失败仍需持续随访。
J Urol. 2009 Apr;181(4):1869-74; discussion 1874-5. doi: 10.1016/j.juro.2008.12.005. Epub 2009 Feb 23.
7
Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter? ureteroneocystostomy 术后和下尿路注射葡聚糖/透明质酸治疗膀胱输尿管反流并发发热性尿路感染——手术方法和成功率重要吗?
J Urol. 2013 Jan;189(1):275-82. doi: 10.1016/j.juro.2012.09.011. Epub 2012 Nov 20.
8
Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure.原发性膀胱输尿管反流患儿内镜治疗的回顾性研究及失败因素的多因素分析
Scand J Urol. 2014 Dec;48(6):565-70. doi: 10.3109/21681805.2014.938695. Epub 2014 Jul 16.
9
Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.前瞻性研究聚二甲基硅氧烷与葡聚糖/透明质酸注射治疗膀胱输尿管反流。
J Urol. 2014 Dec;192(6):1794-9. doi: 10.1016/j.juro.2014.05.116. Epub 2014 Jun 10.
10
Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.从学习曲线中学习:与使用葡聚糖omer/透明质酸共聚物成功进行内镜下膀胱输尿管反流矫正相关的因素。
J Urol. 2008 Oct;180(4 Suppl):1594-9; discussion 1599-600. doi: 10.1016/j.juro.2008.03.084. Epub 2008 Aug 16.

引用本文的文献

1
Evaluation of the Diagnostic Value of Contrast-Enhanced Voiding Urosonography with Regard to the Further Therapy Regime and Patient Outcome-A Single-Center Experience in an Interdisciplinary Uroradiological Setting.对比增强型排空性超声尿路造影对进一步治疗方案和患者预后的诊断价值评估——在多学科泌尿放射学环境中的单中心经验。
Medicina (Kaunas). 2021 Jan 9;57(1):56. doi: 10.3390/medicina57010056.

本文引用的文献

1
The Swedish infant high-grade reflux trial: UTI and renal damage.瑞典婴幼儿重度反流试验:尿路感染与肾损伤
J Pediatr Urol. 2017 Apr;13(2):146-154. doi: 10.1016/j.jpurol.2016.12.023. Epub 2017 Feb 2.
2
Multi-Institutional Review of Outcomes and Complications of Robot-Assisted Laparoscopic Extravesical Ureteral Reimplantation for Treatment of Primary Vesicoureteral Reflux in Children.多机构对机器人辅助腹腔镜膀胱外输尿管再植术治疗儿童原发性膀胱输尿管反流的结果和并发症的综述。
J Urol. 2017 Jun;197(6):1555-1561. doi: 10.1016/j.juro.2017.01.062. Epub 2017 Jan 24.
3
Urinary tract infections in children: EAU/ESPU guidelines.
儿童尿路感染:EAU/ESPU 指南。
Eur Urol. 2015 Mar;67(3):546-58. doi: 10.1016/j.eururo.2014.11.007. Epub 2014 Dec 2.
4
Vesicoscopic ureteral reimplant: is there a role in the age of robotics?膀胱镜下输尿管再植术:在机器人时代有作用吗?
Urol Clin North Am. 2015 Feb;42(1):53-9. doi: 10.1016/j.ucl.2014.09.005. Epub 2014 Nov 20.
5
EAU guidelines on vesicoureteral reflux in children.EAU 指南:儿童膀胱输尿管反流
Eur Urol. 2012 Sep;62(3):534-42. doi: 10.1016/j.eururo.2012.05.059. Epub 2012 Jun 5.
6
Endoscopic treatment of primary vesicoureteral reflux.原发性膀胱输尿管反流的内镜治疗
N Engl J Med. 2012 Mar 29;366(13):1218-26. doi: 10.1056/NEJMct1108922.
7
Durability of antireflux effect of ureteral reimplantation for primary vesicoureteral reflux: findings on long-term cystography.输尿管再植术治疗原发性膀胱输尿管反流的抗反流效果的持久性:长期膀胱造影的结果。
Urology. 2012 Mar;79(3):675-9. doi: 10.1016/j.urology.2011.11.005. Epub 2012 Jan 13.
8
Endoscopic bulking materials for the treatment of vesicoureteral reflux: a review of our 20 years of experience and review of the literature.用于治疗膀胱输尿管反流的内镜填充材料:我们20年经验回顾及文献综述
Adv Urol. 2011;2011:309626. doi: 10.1155/2011/309626. Epub 2011 Apr 6.
9
Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy?我们能否依靠超声检查中葡聚糖微球-透明质酸钠复合物丘的存在来预测注射治疗后膀胱输尿管反流的缓解情况?
J Urol. 2011 Jun;185(6 Suppl):2536-41. doi: 10.1016/j.juro.2011.01.026. Epub 2011 Apr 28.
10
The Swedish reflux trial in children: II. Vesicoureteral reflux outcome.瑞典儿童反流研究 II:膀胱输尿管反流结果。
J Urol. 2010 Jul;184(1):280-5. doi: 10.1016/j.juro.2010.01.059. Epub 2010 May 20.